MALMÖ, Sweden, August 24, 2016 /PRNewswire/ --
Trialbee, an emerging leader in e-clinical solutions is pleased to announce the strategic appointments of Ulf Wiinberg as Chairman of the Board and Lars Birgerson M.D, Ph.D. as member of the board. These appointments bring a wealth of expertise from the life science industry and medical world as Trialbee prepares to further expand business and operations into new market segments.
Ulf Wiinberg brings 30 years' experience from the pharmaceutical industry, most recently as CEO at H.Lundbeck A/S.
Ulf Wiinberg says: "Trialbee's mission to digitalize the clinical trial process has the potential to transform the pharmaceutical industry. With my background I clearly see the value Trialbee bring. I decided to join the board to be part of the journey from start-up to global brand."
Lars Birgerson brings extensive knowledge from Drug Development, Medical Affairs, Health Economics and Outcomes Research. Most recently Lars Birgerson served as Senior Vice President, Medical R&D at Bristol-Myers Squibb (BMS). "Trialbee's solution provides a great opportunity to connect patients and clinical research. Empowering patients is key to secure successful outcomes in the digital era. I'm honoured to bring my expertise and international network to help facilitate this transformation, improving the development of new and better treatments to help patients," says Lars Birgerson.
Tobias Folkesson, CEO and founder of Trialbee, comments:
"I'm very pleased to be adding this wealth of experience and knowledge to the company. I'm proud to have been able to attract individuals of this calibre. This is a clear recognition of our vision to transform clinical trials and digitalize the information flows. As a company we enter a new era to further commercialize our portfolio. I warmly welcome Ulf Wiinberg and Lars Birgerson to the board and remain humble for the deep expertise they bring."
Trialbee help patients engage in clinical research and get access to clinical trials and treatments under development. Trialbee connects all the stakeholders involved in the clinical program enhancing communication and information exchange for faster, more efficient and accurate processes. Trialbee's platform helps pharmaceutical companies shorten the recruitment timelines and brings more motivated and eligible participants to the clinical trials. Trialbee has been recognized through multiple prominent awards and operates from Malmö Sweden.
For further information, please contact:
Tobias Folkesson, CEO, Trialbee